InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: Biostockclub post# 299813

Sunday, 02/21/2021 4:34:33 PM

Sunday, February 21, 2021 4:34:33 PM

Post# of 461256
Actually touting of AVXL by CNBC gives me pause rather than refreshing my positive convictions regarding Anavex.
People in China do not watch the news because they know it is propaganda. Back testing of CNBC leads me to believe that, unless they are reinforcing FAANG+M where a huge percentage of the market is hiding, CNBC is unreliable at best. IMO CNBC besides wanting to gather eyes for its sites and broadcasts to further its interests in advertising revenue may also engage for propaganda.
While I do not actively engage in market timing this CNBC article gives me a reason to wait before further accumulation of AVXL. I do not need reassurance from any media or analysts regarding my investment choices but rather I believe when analysts speak or promote as they are only "talking their book" and there maybe quite a variance between what they offer the public as free analysis and what they provide to Institutions and Hedge Funds for a price.
Cassava might be ripe for a short. If Anavex falls in sympathy I will buy it.
My convictions that analysts are not entirely forthright was recently confirmed and reinforced by the analysts proclamations and the subsequent price action in Sage Therapeutics. Sage was trading at $86 in November, Biogen did a partner deal that included 10% stock at twenty percent premium price $103. It does not take a Wizard of Wall Street to know that was an excellent deal for cash and spreading development risk to Biogen. Big time Wirehouse analysts panned the excellent deal and cut price targets for Sage. Over the next week or so SAGE traded down to $68. I suspected the Wirehouses were lying to the public while advising accumulation to their paying clients. I added SAGE in the low $70s and sold in the mid $90s in about six weeks. Never touching my long term position or having a care in the world for what the analysts say positive or negative. BTW as soon as SAGE rose into the $90s the Wirehouses changed their tune back to positive then SAGE sold off again although not as much.
IMO it is better not to listen to analysts or the likes of CNBC except to deduce possible manipulations.
I believe that AVXL has a good chance to rise 5x from here within the next eighteen months. However I think if CNBC is touting AVXL that might not neccesarily be a good thing. I see no reason that all of a sudden Wall Street shorts will quit F'ng with Anavex. But I intend to hold and maintain Standard Operating Procedure....buying the dips!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News